Viridian Therapeutics, Inc. (VRDN) News
Track canonical SquawkNews coverage tagged to VRDN, Viridian Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
RBC Capital Maintains Outperform on Viridian Therapeutics, Raises Price Target to $35
RBC Capital analyst Lisa Walter maintains Viridian Therapeutics (NASDAQ: VRDN ) with a Outperform and raises the price target from $34 to $35.
EQUITY | Jun 30, 2026, 03:34 PM UTC
L
Truist Securities Maintains Buy on Viridian Therapeutics, Raises Price Target to $38
Truist Securities analyst Gregory Renza maintains Viridian Therapeutics (NASDAQ: VRDN ) with a Buy and raises the price target from $35 to $38.
EQUITY | Jun 30, 2026, 01:58 PM UTC
L
Wedbush Maintains Outperform on Viridian Therapeutics, Raises Price Target to $43
Wedbush analyst Laura Chico maintains Viridian Therapeutics (NASDAQ: VRDN ) with a Outperform and raises the price target from $32 to $43.
EQUITY | Jun 30, 2026, 12:47 PM UTC
M
Wells Fargo Upgrades Viridian Therapeutics to Overweight, Raises Price Target to $31
Wells Fargo analyst Derek Archila upgrades Viridian Therapeutics (NASDAQ: VRDN ) from Equal-Weight to Overweight and raises the price target from $20 to $31.
EQUITY | Jun 29, 2026, 04:53 PM UTC
H
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket
Shares of Universe Pharmaceuticals Inc (NASDAQ: UPC ) rose sharply in pre-market trading after the company announced it will acquire Best Praise International for $10.75 million. Universe Pharmaceuticals shares jumped 22
RATES | Jun 29, 2026, 11:03 AM UTC
M
Needham Reiterates Buy on Viridian Therapeutics, Maintains $32 Price Target
Needham analyst Serge Belanger reiterates Viridian Therapeutics (NASDAQ: VRDN ) with a Buy and maintains $32 price target.
EQUITY | Jun 29, 2026, 10:40 AM UTC
H
Stock Market Today: Dow Jones, S&P 500 Futures Gain As Trump Admin Says US, Iran Will 'Stand Down'—Verizon, HP, Universe Pharmaceuticals In
U.S. stock futures rose on Monday, as the Dow Jones, Nasdaq 100, and S&P 500 indices rose, following Friday’s mixed close. Late Sunday, the Donald Trump administration announced that both the U.S. and Iran will " stand d
MACRO | Jun 29, 2026, 09:11 AM UTC
H
Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Concentrix Corp. (NASDAQ: CNXC ) to post quarterly earnings at $2.6
EARNINGS | Jun 29, 2026, 06:34 AM UTC
H
VRDN: FDA Approves Lumvoa
Viridian Therapeutics receives FDA approval for Lumvoa to treat thyroid eye disease and plans to launch immediately
EQUITY | Jun 26, 2026, 10:03 PM UTC